Another month has come and gone, and with it, several FDA approvals and regulatory updates related to the ever-evolving landscape of pediatric health care. In our March monthly recap, we list our top ...
Fathers who took 2 or more weeks of leave after the birth of their infant were more likely to report longer breastfeeding duration. A study published in BMC Health found that fathers who took 2 or ...
Jay T. Rubinstein, MD, PhD, emphasized that children with hearing loss should receive genetic testing, as the investigational DB-OTO gene therapy demonstrated positive results. Regeneron ...
A surprise mimicker of a rare disorder: 13-year-old female with altered mental status ...
On March 31, 2025, Ascendis Pharma A/S announced it has submitted a new drug application (NDA) to the FDA for navepegritide (TransCon CNP) to treat children with achondroplasia. 1 In a press release ...
A surprise mimicker of a rare disorder: 13-year-old female with altered mental status ...
A surprise mimicker of a rare disorder: 13-year-old female with altered mental status ...
A surprise mimicker of a rare disorder: 13-year-old female with altered mental status ...
A surprise mimicker of a rare disorder: 13-year-old female with altered mental status ...
A surprise mimicker of a rare disorder: 13-year-old female with altered mental status ...
A surprise mimicker of a rare disorder: 13-year-old female with altered mental status ...
A surprise mimicker of a rare disorder: 13-year-old female with altered mental status ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback